研究概要
本研究表明,NK 细胞浸润卵巢癌肿瘤微环境后,会激活以 ATF3 为核心的综合应激反应(ISR)。
中文摘要
肿瘤内缺乏CD8 T细胞或自然杀伤(NK)细胞等细胞毒性效应细胞,会形成免疫“冷”型肿瘤微环境(TME),导致免疫治疗应答差,卵巢癌中可观察到这一现象。尽管既往研究提示TME中NK细胞耗竭与铁死亡相关,但具体机制尚不清楚。本研究显示,NK细胞浸润卵巢癌TME后,会启动以ATF3为核心的整合应激反应(ISR)。ATF3介导的ISR抑制NRF2表达,削弱NK细胞对抗氧化应激的能力,最终诱发铁死亡。关键的是,我们显示ISR抑制剂ISRIB与NK细胞联合治疗,不仅可防止NK细胞铁死亡,还能协同增强肿瘤细胞杀伤。这些发现为理解TME中NK细胞耗竭机制提供新见解,并确定ISR抑制是开发NK细胞疗法治疗卵巢癌的有前景靶点和干预策略。
展开英文摘要原文
The absence of cytotoxic effector cells, such as CD8 T cells or Natural Killer (NK) cells, within tumors establishes an immune-cold tumor microenvironment (TME), contributing to poor immunotherapy responses, as observed in ovarian cancer. Although prior studies implicate NK cell exhaustion within the TME related to ferroptosis, the underlying mechanisms remain undefined. This study demonstrates that upon infiltrating the ovarian cancer TME, NK cells activate an integrated stress response (ISR) centered on ATF3. This ATF3-mediated ISR suppresses NRF2 expression, compromising their ability to counteract oxidative stress and ultimately triggering ferroptosis. Critically, we show that co-treatment with the ISR inhibitor ISRIB and NK cells not only prevents NK cell ferroptosis but also synergizes to enhance tumor cell killing. These findings provide novel insights into the mechanisms driving NK cell exhaustion within the TME and identify ISR inhibition as a promising therapeutic target and intervention strategy for developing NK cell-based therapies against ovarian cancer.
论文信息
- 作者
- Chen T、Zhou S、Zhang Y、Meng H、Miao H、Feng M、Jiang Y、Wan Y
- 单位
- Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.China
- 文献类型
- 非美国政府资助研究
- 期刊
- International journal of biological sciences2025